American Psychological Association 6th edition

Xiaosong Li, Wei Ding, & Hong Zhang. (2023). Cinacalcet use in secondary hyperparathyroidism: a machine learning-based systematic review. Frontiers in Endocrinology, 1-16. https://doi.org/10.3389/fendo.2023.1146955

ISO-690 (author-date, English)

XIAOSONG LI, WEI DING und HONG ZHANG, 2023. Cinacalcet use in secondary hyperparathyroidism: a machine learning-based systematic review. Frontiers in Endocrinology. 2 August 2023. P. 1-16. DOI 10.3389/fendo.2023.1146955.

Modern Language Association 9th edition

Xiaosong Li, Wei Ding, und Hong Zhang. „Cinacalcet Use in Secondary Hyperparathyroidism: A Machine Learning-Based Systematic Review.“. Frontiers in Endocrinology, August 2023, S. 1-16, https://doi.org/10.3389/fendo.2023.1146955.

Mohr Siebeck - Recht (Deutsch - Österreich)

Xiaosong Li/Wei Ding/Hong Zhang: Cinacalcet use in secondary hyperparathyroidism: a machine learning-based systematic review., Frontiers in Endocrinology 2023, 1-16.

Emerald - Harvard

Xiaosong Li, Wei Ding und Hong Zhang. (2023), „Cinacalcet use in secondary hyperparathyroidism: a machine learning-based systematic review.“, Frontiers in Endocrinology, S. 1-16.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.